Vanda Pharmaceuticals Inc (VNDA)
4.845
+0.18
(+3.97%)
USD |
NASDAQ |
Nov 04, 13:14
Vanda Pharmaceuticals Market Cap: 282.41M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 271.63M |
| October 31, 2024 | 271.05M |
| October 30, 2024 | 265.80M |
| October 29, 2024 | 273.38M |
| October 28, 2024 | 278.63M |
| October 25, 2024 | 265.22M |
| October 24, 2024 | 263.47M |
| October 23, 2024 | 273.38M |
| October 22, 2024 | 275.71M |
| October 21, 2024 | 275.71M |
| October 18, 2024 | 286.20M |
| October 17, 2024 | 276.00M |
| October 16, 2024 | 285.62M |
| October 15, 2024 | 279.79M |
| October 14, 2024 | 280.37M |
| October 11, 2024 | 258.81M |
| October 10, 2024 | 257.06M |
| October 09, 2024 | 260.56M |
| October 08, 2024 | 261.72M |
| October 07, 2024 | 262.30M |
| October 04, 2024 | 269.88M |
| October 03, 2024 | 262.30M |
| October 02, 2024 | 267.55M |
| October 01, 2024 | 264.64M |
| September 30, 2024 | 273.38M |
| Date | Value |
|---|---|
| September 27, 2024 | 272.21M |
| September 26, 2024 | 276.29M |
| September 25, 2024 | 282.71M |
| September 24, 2024 | 289.12M |
| September 23, 2024 | 276.88M |
| September 20, 2024 | 268.72M |
| September 19, 2024 | 271.05M |
| September 18, 2024 | 288.53M |
| September 17, 2024 | 287.95M |
| September 16, 2024 | 296.11M |
| September 13, 2024 | 297.28M |
| September 12, 2024 | 290.87M |
| September 11, 2024 | 286.79M |
| September 10, 2024 | 290.28M |
| September 09, 2024 | 292.61M |
| September 06, 2024 | 292.61M |
| September 05, 2024 | 296.11M |
| September 04, 2024 | 296.11M |
| September 03, 2024 | 296.11M |
| August 30, 2024 | 308.35M |
| August 29, 2024 | 304.27M |
| August 28, 2024 | 307.19M |
| August 27, 2024 | 311.85M |
| August 26, 2024 | 320.01M |
| August 23, 2024 | 318.26M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
194.46M
Minimum
Nov 09 2023
1.197B
Maximum
Jun 30 2021
581.59M
Average
584.57M
Median
Nov 23 2022
Market Cap Benchmarks
| Zevra Therapeutics Inc | 451.46M |
| Edgewise Therapeutics Inc | 3.182B |
| NovaBay Pharmaceuticals Inc | 3.652M |
| Palatin Technologies Inc | 23.46M |
| iBio Inc | 23.67M |
Market Cap Related Metrics
| PS Ratio | 1.539 |
| Price to Book Value | 0.5206 |
| Price | 4.845 |
| Earnings Yield | -3.87% |